Zeria Pharmaceutical Co., Ltd.
Notice of Revision to Year-end Dividend Forecast (Increase)
Taking into account results through the second quarter, the company has raised the year-end dividend forecast for the fiscal year ending March 2027 to 26 yen per share, bringing the full-year dividend to 51 yen. The previous forecast was year-end 26 yen / full-year 50 yen; the prior fiscal year actual was a total of 49 yen.
Key Figures
- Annual dividend per share: 51 yen
- Dividend at the end of the second quarter: 26 yen
- Year-end dividend forecast: 26 yen
AI要約
Dividend Policy and Details of Revision
The company, which regards shareholder returns as one of its most important management priorities and has a basic policy of stable and continuous dividends, has revised upward the year-end dividend forecast for the fiscal year ending March 2027 to 26 yen per share based on results through the second quarter. As a result, the full-year dividend will be 51 yen. The previous forecast was year-end 26 yen / full-year 50 yen, with no changes during the interim period.
Impact on Shareholders and Outlook
This dividend increase strengthens returns to shareholders and supports the full-year dividend payout ratio. Although specifics such as the record date are not provided in this release, the company indicates it will maintain a stable dividend policy while remaining flexible in response to future business performance trends.
Zeria Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
